Phase I, Open-Label Study of the Safety, Tolerability, and Immunogenicity PEK Fusion Protein Vaccine

Clinical trial NCT01880411 · UNKNOWN

Trial details

NCT number: NCT01880411
Sponsor: HealthBanks Biotech Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Cervical Intraepithelial Neoplasia

Start date: 2013-06-01
Primary completion: 2014-01-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.